1-8 of 8
Uri Martinowitz
Close
Sort by
Journal Articles

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Clinical Trials & Observations
Elena Santagostino, Uri Martinowitz, Toshko Lissitchkov, Brigitte Pan-Petesch, Hideji Hanabusa, Johannes Oldenburg, Lisa Boggio, Claude Negrier, Ingrid Pabinger, Mario von Depka Prondzinski, Carmen Altisent, Giancarlo Castaman, Koji Yamamoto, Maria-Teresa Álvarez-Roman, Christine Voigt, Nicole Blackman, Iris Jacobs
Journal: Blood
Blood (2016) 127 (14): 1761–1769.
https://doi.org/10.1182/blood-2015-09-669234
Published: 2016
Includes: Supplemental data
Journal Articles

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

Aaron Lubetsky, MD, Uri Martinowitz, MD, Toshko Lissitchkov, MD, Christine Voigt, PhD, Denise Wolko, Iris C. Jacobs, MD, Elena Santagostino, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1096.
https://doi.org/10.1182/blood.V126.23.1096.1096
Published: 2015
Journal Articles

Efficacy, PK and Safety Results of Clinical Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) In Previously Treated Patients With Hemophilia B

Aaron Lubetsky, MD MSc, Toshko Lissitchkov, MD, Elena Santagostino, MD, PhD, Gantcho Jotov, MD, Tami Barazani-Brutman, Ph.D, Christine Voigt, Ph.D, Tina Moises, Ph.D, Iris C. Jacobs, MD, Uri Martinowitz, MD
Journal: Blood
Blood (2013) 122 (21): 1109.
https://doi.org/10.1182/blood.V122.21.1109.1109
Published: 2013
Journal Articles

Trace FVIII Augments Rfviia Induced Thrombin Generation and Improves Hemostasis in Hemophilia A Patients with Inhibitors: A clinical Cohort Study

Tami Livnat, PhD, Uri Martinowitz, MD, Shirley Azar-Avivi, Ariela Zivelin, PhD, Gili Kenet, MD
Journal: Blood
Blood (2012) 120 (21): 40.
https://doi.org/10.1182/blood.V120.21.40.40
Published: 2012
Journal Articles

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Uri Martinowitz, MD, Amy D. Shapiro, MD, Doris V. Quon, MD, PhD, Miguel Antonio Escobar, MD, Christine L Kempton, MD, MSc, Peter Collins, MD, Pratima Chowdary, MD, Michael Makris, MD, Pier Mannuccio Mannucci, MD, Massimo Morfini, MD, Leonard A. Valentino, MD, Edward D. Gomperts, MD, Martin Lee, PhD
Journal: Blood
Blood (2011) 118 (21): 2267.
https://doi.org/10.1182/blood.V118.21.2267.2267
Published: 2011
Journal Articles

Recombinant Porcine Factor VIII Corrects Thrombin Generation and Improves Clot Structure In Vitro in Plasma Containing Anti-Factor VIII Inhibitory Antibodies

Claude Negrier, Shannon L. Meeks, MD, Johannes Oldenburg, Uri Martinowitz, Jean-Claude Bordet, Bernd Poetzsch, Raed Al Dieri, Yesim Dargaud, Coen Hemker, Carel Eckmann, Ed Gomperts, Martin Lee
Journal: Blood
Blood (2011) 118 (21): 2282.
https://doi.org/10.1182/blood.V118.21.2282.2282
Published: 2011
Journal Articles

Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.

Uri Martinowitz, Aaron Lubetsky, Ilia Tamarin, Jacob Luboshitz
Journal: Blood
Blood (2004) 104 (11): 4114.
https://doi.org/10.1182/blood.V104.11.4114.4114
Published: 2004
Journal Articles

Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C

Ariella Zivelin, Sanford Gitel, John H. Griffin, Xiao Xu, Jose A. Fernandez, Uri Martinowitz, Yael Cohen, Hillel Halkin, Uri Seligsohn, Aida Inbal
Journal: Blood
Blood (1999) 94 (3): 895–901.
https://doi.org/10.1182/blood.V94.3.895.415k01_895_901
Published: 1999